National Health Investors, Inc. (NYSE:NHI) Declares $0.90 Quarterly Dividend

National Health Investors, Inc. (NYSE:NHI) declared a quarterly dividend on Monday, May 6th, Wall Street Journal reports. Investors of record on Friday, June 28th will be given a dividend of 0.90 per share by the real estate investment trust on Friday, August 2nd. This represents a $3.60 annualized dividend and a yield of 5.55%. The ex-dividend date is Friday, June 28th.

National Health Investors has raised its dividend by an average of 0.9% per year over the last three years and has raised its dividend annually for the last 1 consecutive years. National Health Investors has a payout ratio of 119.6% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Analysts expect National Health Investors to earn $4.53 per share next year, which means the company should continue to be able to cover its $3.60 annual dividend with an expected future payout ratio of 79.5%.

National Health Investors Stock Down 1.3 %

Shares of NHI traded down $0.83 during mid-day trading on Wednesday, reaching $64.82. The company’s stock had a trading volume of 14,087 shares, compared to its average volume of 169,493. The company’s 50 day moving average is $60.81 and its 200 day moving average is $56.48. The company has a debt-to-equity ratio of 0.90, a current ratio of 10.27 and a quick ratio of 10.27. The stock has a market cap of $2.81 billion, a PE ratio of 20.98 and a beta of 0.95. National Health Investors has a 12-month low of $48.51 and a 12-month high of $66.10.

Insider Transactions at National Health Investors

In other National Health Investors news, Director Charlotte A. Swafford purchased 10,000 shares of National Health Investors stock in a transaction on Tuesday, February 27th. The shares were purchased at an average cost of $58.69 per share, with a total value of $586,900.00. Following the completion of the transaction, the director now directly owns 110,185 shares in the company, valued at approximately $6,466,757.65. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 8.21% of the company’s stock.

Wall Street Analysts Forecast Growth

NHI has been the subject of several research analyst reports. Deutsche Bank Aktiengesellschaft initiated coverage on shares of National Health Investors in a report on Tuesday, January 30th. They issued a “buy” rating and a $69.00 target price for the company. Truist Financial boosted their target price on National Health Investors from $55.00 to $58.00 and gave the company a “hold” rating in a report on Thursday, April 4th. Wells Fargo & Company raised National Health Investors from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $55.00 to $63.00 in a research report on Monday, February 26th. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Finally, Wedbush upped their price target on shares of National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a research report on Monday, March 18th. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, National Health Investors has an average rating of “Hold” and a consensus price target of $60.50.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.